Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7513710 | International Journal of Drug Policy | 2014 | 28 Pages |
Abstract
Georgian PWID are very exposed to HCV and have high levels of severe liver fibrosis. Hence, harm reduction services should be scaled-up in Georgia and HCV treatment programmes should be implemented straight away and should include active drug users. Other risk factors for liver fibrosis, such as hepatitis B, should be specifically addressed in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Julie Bouscaillou, Julie Champagnat, Niklas Luhmann, Elisabeth Avril, Ina Inaridze, Véronique Miollany, Koka Labartkava, Irma Kirtadze, Maia Butsashvili, George Kamkamidze, Dominique Pataut,